Ben Haynor

Stock Analyst at Lake Street

(0.54)
# 3,807
Out of 4,712 analysts
38
Total ratings
23.68%
Success rate
-25.13%
Average return

Stocks Rated by Ben Haynor

Treace Medical Concepts
Dec 31, 2024
Initiates: Buy
Price Target: $15
Current: $7.44
Upside: +94.89%
Ekso Bionics Holdings
Oct 29, 2024
Maintains: Buy
Price Target: $2.5$2
Current: $0.61
Upside: +227.87%
Aspira Women's Health
Aug 14, 2024
Maintains: Buy
Price Target: $7$5.5
Current: $0.71
Upside: +680.14%
Myomo
Jul 9, 2024
Maintains: Buy
Price Target: $7$7.5
Current: $6.44
Upside: +16.46%
IceCure Medical
Mar 20, 2024
Maintains: Buy
Price Target: $1.9$2.9
Current: $1.10
Upside: +163.64%
Profound Medical
Mar 11, 2024
Maintains: Buy
Price Target: $13$11
Current: $7.51
Upside: +43.81%
Evogene
Oct 2, 2023
Initiates: Buy
Price Target: $19
Current: $1.87
Upside: +889.30%
Nano-X Imaging
Sep 8, 2023
Initiates: Buy
Price Target: $15
Current: $7.20
Upside: +101.39%
NeuroOne Medical Technologies
Aug 15, 2023
Maintains: Buy
Price Target: $3.25$2.2
Current: $0.83
Upside: +166.38%
DarioHealth
Aug 11, 2023
Maintains: Buy
Price Target: $5.45$4.1
Current: $0.79
Upside: +421.56%
Maintains: Neutral
Price Target: $12$7
Current: $0.42
Upside: +1,566.67%
Maintains: Buy
Price Target: $10$5.55
Current: $2.30
Upside: +141.30%
Maintains: Buy
Price Target: $5.15$4.75
Current: $2.63
Upside: +80.61%
Maintains: Buy
Price Target: $15$7
Current: $6.92
Upside: +1.16%
Initiates: Buy
Price Target: $23
Current: $3.60
Upside: +531.94%
Maintains: Buy
Price Target: $15,950$13,485
Current: $4.46
Upside: +302,254.26%
Initiates: Buy
Price Target: $1,375
Current: $2.45
Upside: +56,022.45%